How Droplet Digital PCR Has Revolutionized Non-Invasive Plasma-Based Detection of Mutations
15 Oct 2014

There is an unmet need for assays that monitor and detect the emergence of resistance mutations to targeted therapies, especially for advanced solid tumors where tissue availability is limiting. This case study from Bio-Rad describes how droplet digital PCR allows detection of EGFR T790M mutations in circulating tumor DNA.

Show    per page
1 of 1     Page  1 Next 
Protein Purification Workflow Development Using Bio-Rad’s NGC™ Chromatography System protein purification11 Feb 2014Read

Popular tags in SelectScience